Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effects of Ketorolac 15mg IV Versus 30mg IV on Duration of Analgesia in Patients Who Present to the Emergency Department With Renal Colic

NCT05776953 is registered in ClinicalTrials.gov with Hackensack Meridian Health as lead sponsor.

NCT NCT05776953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05776953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effects of Ketorolac 15mg IV Versus 30mg IV on Duration of Analgesia in Patients Who Present to the Emergency Department With Renal Colic
Lead sponsor
Hackensack Meridian Health
Phase
Phase 4
Overall status
Completed
Start date
December 21, 2023
Completion date
August 12, 2026
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, emergencies, flank pain, renal colic